Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;17(1):e13088.
doi: 10.1111/irv.13088. Epub 2022 Dec 28.

Effect of COVID-19 vaccine on menstrual experience among females in six Arab countries: A cross sectional study

Affiliations

Effect of COVID-19 vaccine on menstrual experience among females in six Arab countries: A cross sectional study

Sajeda Ghassan Matar et al. Influenza Other Respir Viruses. 2023 Jan.

Abstract

Background: There have been varying reports on the potential occurrence and severity of changes to menstruation including the median cycle length, days of bleeding, bleeding heaviness, and menstrual pain, following receipt of COVID-19 vaccinations. We aimed to assess potential postvaccination menstrual changes in women residing in the Middle East.

Methods: We implemented a cross-sectional online survey-based study. Data about the participants' demographic characteristics, menstruation experience, and vaccination status were collected and analyzed among six Arab countries.

Results: Among 4942 menstruating females included in this study, females who had received one or more doses of COVID-19 vaccination reported a higher frequency of back pain, nausea, tiredness, pelvic pain with periods, unprescribed analgesics use, and passage of loose stools. They also reported higher scores describing average and worst menstrual pain. Fully vaccinated females reported heavier flow and more days of bleeding.

Conclusion: Our findings indicate that COVID-19 vaccine may have an effect on menstruation in terms of menstrual pain and bleeding heaviness. The evidence needs to be further investigated in longitudinal studies.

Keywords: COVID-19; cross-sectional; menstrual health; menstruation; vaccine; women's health.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Coronavirus disease (COVID‐19) Pandemic [Internet]. WHO [cited 2022 May 28]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
    1. Ura T, Yamashita A, Mizuki N, Okuda K, Shimada M. New vaccine production platforms used in developing SARS‐CoV‐2 vaccine candidates. Vaccine [Internet]. 2021;39(2):197‐201. doi:10.1016/j.vaccine.2020.11.054 - DOI - PMC - PubMed
    1. Pormohammad A, Zarei M, Ghorbani S, et al. Efficacy and safety of COVID‐19 vaccines: A systematic review and meta‐analysis of randomized clinical trials. Vaccine. 2021;9:467. doi:10.2139/ssrn.3812422 - DOI - PMC - PubMed
    1. Gresele P, Marietta M, Ageno W, et al. Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET). Blood Transfus [Internet]. 2021;19(4):281‐283. https://pubmed.ncbi.nlm.nih.gov/33871350 - PMC - PubMed
    1. el‐Shitany NA, Harakeh S, Badr‐Eldin SM, et al. Minor to moderate side effects of Pfizer‐BioNTech COVID‐19 vaccine among Saudi residents: A retrospective cross‐sectional study. Int J Gen Med [Internet]. 2021;14:1389‐1401. doi:10.2147/IJGM.S310497 - DOI - PMC - PubMed

Substances